Physician profile
Khursheed Ahmed
NPI 1619917523
$1,480.94
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $358 · 2021: $119 · 2022: $192 · 2023: $169 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $519.20 | 2019-2024 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $309.76 | 2020-2024 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.21 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $125.00 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.81 | 2022 | |
| Amgen INC. | $44.21 | 2023-2024 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $39.06 | 2023-2024 | Mounjaro, Zepbound |
| Boston Scientific Corporation | $26.84 | 2023 | Watchman Access System |
| Exact Sciences Corporation | $23.71 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $14.43 | 2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $13.71 | 2024 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khursheed Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.